$ADMA Stock Alert: ADMA Biologics Securities Class Action Filed After 29% Stock Drop Tied to Channel Stuffing Claims - August 10 Lead Plaintiff Deadline
Bleichmar Fonti & Auld LLP issued a shareholder-solicitation notice regarding a class action lawsuit against ADMA Biologics. The suit alleges securities fraud tied to channel stuffing of ASCENIV and undisclosed related-party transactions. The firm claims ADMA's reported 20% revenue growth for 2025 masked a 3% decline, citing a short report by Culper Research. Investors have until August 10, 2026, to move for lead plaintiff status in the U.S.
Key figures
- Stock drop march 24
- 16.6%
- Stock drop march 25
- 15%
- Stock drop march 29
- 13.9%
- Reported 2025 growth
- 20%
- Lead plaintiff deadline
- August 10, 2026
- Alleged real 2025 growth
- -3%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.